Literature DB >> 22307272

Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.

Young Cheol Weon1, Sun-Won Park, Hyung-Jin Kim, Han-Sin Jeong, Young-Hyeh Ko, In Suh Park, Sung Tae Kim, Chung Hwan Baek, Young-Ik Son.   

Abstract

INTRODUCTION: Salivary duct carcinoma (SDC) is an uncommon high grade adenocarcinoma of the salivary gland with a grave prognosis. The aim of this study was to investigate the clinical and CT and MR imaging features of SDC.
METHODS: We retrospectively evaluated the clinical and CT and MR imaging findings in 20 patients (14 men and six women; mean age, 59 years) with histologically proved SDC. We also tried to correlate clinicoradiological tumor staging with pathologic tumor staging in 17 patients who underwent surgery.
RESULTS: The tumor originated in the parotid gland (n = 11; 55%), the submandibular gland (n = 7; 35%) and the buccal space along the distal Stensen's duct (n = 2; 10%). Locoregional recurrence occurred in 41% and distant metastasis in 47%. Fifty-eight percent died of the disease with a mean survival period of 32 months after diagnosis. On CT and MR images, SDC was mostly seen as an ill-defined (85%) and infiltrative (60%) mass with frequent calcification (50%) and necrosis (80%). Although various signal intensities were seen on MR images, six of nine tumors contained the areas of marked hypointensity on T2-weighted images. Clinicoradiological tumor staging correlated well with pathologic tumor staging in 82% of the patients.
CONCLUSION: Ill-defined, infiltrative mass with calcification on CT scans and the areas of marked hypointensity on T2-weighted MR images may be useful radiologic features to suggest the diagnosis of SDC. CT and MR imaging are useful for staging of SDC.

Entities:  

Mesh:

Year:  2012        PMID: 22307272     DOI: 10.1007/s00234-012-1014-z

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  29 in total

1.  Intraoral salivary duct carcinoma: a report of 5 cases.

Authors:  Willie F P van Heerden; Erich J Raubenheimer; Theuns J P Swart; Sonja C Boy
Journal:  J Oral Maxillofac Surg       Date:  2003-01       Impact factor: 1.895

2.  Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy.

Authors:  S Eida; M Sumi; N Sakihama; H Takahashi; T Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

3.  [Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma].

Authors:  O Kleinsasser; H J Klein; G Hübner
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1968

4.  Salivary duct carcinoma--a clinicopathologic study of 12 cases.

Authors:  L E Afzelius; W R Cameron; C Svensson
Journal:  Head Neck Surg       Date:  1987 Jan-Feb

5.  Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts). A clinicopathologic and immunohistochemical study of 12 cases.

Authors:  M S Brandwein; J Jagirdar; J Patil; H Biller; M Kaneko
Journal:  Cancer       Date:  1990-05-15       Impact factor: 6.860

6.  Tumors of the parotid gland: MR imaging characteristics of various histologic types.

Authors:  V Q Joe; P L Westesson
Journal:  AJR Am J Roentgenol       Date:  1994-08       Impact factor: 3.959

7.  Salivary duct carcinoma: an analysis of four cases with review of literature.

Authors:  T A Garland; D J Innes; R E Fechner
Journal:  Am J Clin Pathol       Date:  1984-04       Impact factor: 2.493

8.  Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.

Authors:  Hidetake Yabuuchi; Tatsuro Fukuya; Tsuyoshi Tajima; Yoichi Hachitanda; Kichinobu Tomita; Mitsuru Koga
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

9.  Salivary duct carcinoma.

Authors:  R T Grenko; P Gemryd; M Tytor; P G Lundqvist; B Boeryd
Journal:  Histopathology       Date:  1995-03       Impact factor: 5.087

Review 10.  Salivary duct carcinoma. Part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature.

Authors:  L Barnes; U Rao; J Krause; L Contis; A Schwartz; P Scalamogna
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1994-07
View more
  9 in total

Review 1.  Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.

Authors:  Masato Nakaguro; Yuichiro Tada; William C Faquin; Peter M Sadow; Lori J Wirth; Toshitaka Nagao
Journal:  Cancer Cytopathol       Date:  2020-05-18       Impact factor: 5.284

2.  Microcalcifications in stone-obstructed human submandibular gland are associated with apoptosis and cell proliferation.

Authors:  Ivan Lau; Ajay Potluri; Cliff-Lawrence Ibeh; Robert S Redman; Edina Paal; Bidhan C Bandyopadhyay
Journal:  Arch Oral Biol       Date:  2017-06-07       Impact factor: 2.633

Review 3.  Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging.

Authors:  Angelo Castello; Laura Olivari; Egesta Lopci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

4.  Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.

Authors:  Kenta Kawahara; Akimitsu Hiraki; Ryoji Yoshida; Hidetaka Arita; Yuichiro Matsuoka; Toshio Yamashita; Kan-Ichi Koga; Masashi Nagata; Akiyuki Hirosue; Daiki Fukuma; Hideki Nakayama
Journal:  Mol Clin Oncol       Date:  2017-04-21

5.  Frequency and imaging features of the adjacent osseous changes of salivary gland carcinomas in the head and neck region.

Authors:  Daisuke Horiuchi; Taro Shimono; Hiroyuki Tatekawa; Taro Tsukamoto; Hirotaka Takita; Masahiro Okazaki; Yukio Miki
Journal:  Neuroradiology       Date:  2022-05-07       Impact factor: 2.995

6.  The radiologic (CT/MRI)-pathological correlations of the salivary duct carcinoma (SDC) with hyaline degeneration and peripheral nerve invasion.

Authors:  Nobukata Kazawa; Yuta Shibamoto; Yasujirou Hirose; Yoriko Yamashita
Journal:  Dentomaxillofac Radiol       Date:  2021-04-20       Impact factor: 3.525

7.  Salivary duct carcinoma of the submandibular gland presenting a diagnostic challenge: A case report.

Authors:  Toshihiro Uchihashi; Shingo Kodama; Akinari Sugauchi; Shinichiro Hiraoka; Katsutoshi Hirose; Yu Usami; Susumu Tanaka; Mikihiko Kogo
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

8.  Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature.

Authors:  Yongfei You; Panpan Wang; Xi Wan; Liping Xu; Yi Gong; Weihua Zhang
Journal:  Onco Targets Ther       Date:  2021-05-28       Impact factor: 4.147

9.  Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors.

Authors:  Makoto Shinoto; Yoshiyuki Shioyama; Katsumasa Nakamura; Torahiko Nakashima; Naonobu Kunitake; Yuichiro Higaki; Tomonari Sasaki; Saiji Ohga; Tadamasa Yoshitake; Kayoko Ohnishi; Kaori Asai; Hideki Hirata; Hiroshi Honda
Journal:  J Radiat Res       Date:  2013-04-04       Impact factor: 2.724

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.